Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 50 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

22%

11 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

N/A
21(60.0%)
Phase 3
11(31.4%)
Phase 1
1(2.9%)
Phase 2
1(2.9%)
Early Phase 1
1(2.9%)
35Total
N/A(21)
Phase 3(11)
Phase 1(1)
Phase 2(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (50)

Showing 20 of 50 trials
NCT07352488Not ApplicableNot Yet Recruiting

Modified Shenling Baizhu Powder for Allergic Asthma With Spleen Deficiency and Dampness Accumulation Syndrome

Role: lead

NCT07206745Not ApplicableNot Yet Recruiting

A Study on Integrated Chinese and Western Medicine for Severe Pneumonia Caused by Multidrug-Resistant Gram-Negative Bacterial Infections

Role: lead

NCT07178392Not Yet Recruiting

Disease-syndrome Characteristics of IPF

Role: lead

NCT07162870Not Yet Recruiting

Idiopathic Pulmonary Fibrosis Cohort of TCM

Role: lead

NCT07131020Not ApplicableRecruiting

Study on the Mechanism of Yifei Moxibustion Improving Immune Function in COPD Based on Plasma Exosome miRNAs

Role: lead

NCT06914713Not ApplicableNot Yet Recruiting

Jin-shui Huan-xian Formula for Retarding the Decline of Pulmonary Function in IPF

Role: lead

NCT06963333Not ApplicableNot Yet Recruiting

Clinical Study on Improving Exercise Capacity in Chronic Obstructive Pulmonary Disease Through Smart IoT-Remote Home Breathing Guidance

Role: lead

NCT06918353Not Yet Recruiting

The Severity Assessment Model for AECOPD With Combination of Disease and Syndrome

Role: lead

NCT06869525Not ApplicableNot Yet Recruiting

Study on Acupuncture Treatment of Chronic Airway Diseases(Asthma and Chronic Obstructive Pulmonary Disease)

Role: lead

NCT06220019Not Yet Recruiting

REspiratory diSEAse cohoRt Studies of CHinese Medicine for Pneumonia (RESEARCH-Pneumonia)

Role: lead

NCT06747325Not ApplicableNot Yet Recruiting

Clinical Trial of Fei Re Qing Granules in the Treatment of Elderly Community-Acquired Pneumonia

Role: lead

NCT06714032Phase 3Completed

Effect of Traditional Chinese Medicine of Severe COVID-19

Role: lead

NCT06691802Not ApplicableNot Yet Recruiting

Clinical Study on the Treatment of Chronic Airway Diseases (Asthma, Chronic Obstructive Pulmonary Disease) with Shu Fei Tie

Role: lead

NCT06685315Not Yet Recruiting

Research on the Characteristics of Chronic Airway Diseases (asthma, COPD)

Role: lead

NCT06455670Not ApplicableNot Yet Recruiting

Effects of Chinese Medicine on Patients With Severe Acute Exacerbation of COPD

Role: lead

NCT06613659Not Yet Recruiting

Cohort Study on the Treatment of Severe Pneumonia with Traditional Chinese Medicine

Role: lead

NCT06406166Not ApplicableRecruiting

Lifei Xiaoji Wan in Treatment of Advanced NSCLC

Role: lead

NCT06577701Not Yet Recruiting

Respiratory Disease Cohort Studies of Chinese Medicine for COPD(RESEARCH-COPD)

Role: lead

NCT06577753Recruiting

REspiratory diSEAse cohoRt Studies of CHinese Medicine for ILD (RESEARCH-ILD)

Role: lead

NCT06573450Recruiting

Exhaled Breath Condensate Biomarkers in CARAS

Role: lead